Chih‐Yun Lin

1.2k total citations
33 papers, 965 citations indexed

About

Chih‐Yun Lin is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Chih‐Yun Lin has authored 33 papers receiving a total of 965 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hepatology, 20 papers in Epidemiology and 10 papers in Surgery. Recurrent topics in Chih‐Yun Lin's work include Hepatocellular Carcinoma Treatment and Prognosis (18 papers), Liver Disease Diagnosis and Treatment (18 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers). Chih‐Yun Lin is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (18 papers), Liver Disease Diagnosis and Treatment (18 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers). Chih‐Yun Lin collaborates with scholars based in Taiwan, China and United States. Chih‐Yun Lin's co-authors include Jing‐Houng Wang, Chao‐Long Chen, Sheng‐Nan Lu, Tsung‐Hui Hu, Kwong‐Ming Kee, Chih‐Chi Wang, Chi‐Sin Changchien, Chien‐Hung Chen, Chuan‐Mo Lee and Chuan–Mo Lee and has published in prestigious journals such as PLoS ONE, International Journal of Cancer and European Journal of Cancer.

In The Last Decade

Chih‐Yun Lin

30 papers receiving 949 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chih‐Yun Lin Taiwan 13 673 491 265 193 139 33 965
Francesca Ciccarese Italy 16 455 0.7× 364 0.7× 335 1.3× 135 0.7× 140 1.0× 44 896
Kouji Joko Japan 16 729 1.1× 533 1.1× 149 0.6× 106 0.5× 165 1.2× 59 903
Tianfu Wen China 18 567 0.8× 301 0.6× 279 1.1× 189 1.0× 165 1.2× 56 759
Hatsue Fujino Japan 16 538 0.8× 465 0.9× 121 0.5× 83 0.4× 115 0.8× 64 776
Akira Arimoto Japan 15 360 0.5× 252 0.5× 337 1.3× 125 0.6× 298 2.1× 52 792
Yasuaki Kuwata Japan 12 419 0.6× 240 0.5× 249 0.9× 75 0.4× 182 1.3× 31 699
Weiqiang Ju China 17 400 0.6× 261 0.5× 411 1.6× 208 1.1× 113 0.8× 74 948
Fang‐Ying Kuo Taiwan 16 255 0.4× 224 0.5× 205 0.8× 99 0.5× 150 1.1× 47 645
Akihiko Oshita Japan 17 424 0.6× 275 0.6× 440 1.7× 59 0.3× 194 1.4× 68 821
Alessio Bridda Italy 9 337 0.5× 215 0.4× 197 0.7× 81 0.4× 91 0.7× 12 574

Countries citing papers authored by Chih‐Yun Lin

Since Specialization
Citations

This map shows the geographic impact of Chih‐Yun Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chih‐Yun Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chih‐Yun Lin more than expected).

Fields of papers citing papers by Chih‐Yun Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chih‐Yun Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chih‐Yun Lin. The network helps show where Chih‐Yun Lin may publish in the future.

Co-authorship network of co-authors of Chih‐Yun Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Chih‐Yun Lin. A scholar is included among the top collaborators of Chih‐Yun Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chih‐Yun Lin. Chih‐Yun Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Yen, Yi‐Hao, Kwong‐Ming Kee, Chao‐Hung Hung, et al.. (2025). Overall survival was inferior in octogenarians with early-stage hepatocellular carcinoma undergoing percutaneous radiofrequency ablation. The American Journal of the Medical Sciences. 370(3). 278–284.
3.
Yen, Yi‐Hao, et al.. (2024). A simple model to predict early recurrence of hepatocellular carcinoma after liver resection. Langenbeck s Archives of Surgery. 409(1). 261–261.
5.
Yen, Yi‐Hao, Kwong‐Ming Kee, Weifeng Li, et al.. (2023). Stationary Trend in Elevated Serum Alpha-Fetoprotein Level in Hepatocellular Carcinoma Patients. Cancers. 15(4). 1222–1222. 6 indexed citations
6.
Li, Weifeng, Sin‐Hua Moi, Yueh‐Wei Liu, et al.. (2023). Using the hazard function to evaluate hepatocellular carcinoma recurrence risk after curative resection. Updates in Surgery. 75(8). 2147–2155. 1 indexed citations
7.
Yen, Yi‐Hao, Kwong‐Ming Kee, Weifeng Li, et al.. (2023). Causes of Death among Patients with Hepatocellular Carcinoma According to Chronic Liver Disease Etiology. Cancers. 15(6). 1687–1687. 13 indexed citations
8.
Liu, Yueh‐Wei, Sin‐Hua Moi, Weifeng Li, et al.. (2023). A preoperative model for predicting early recurrence in patients undergoing resection for single hepatocellular carcinoma. European Journal of Surgical Oncology. 49(8). 1444–1449. 4 indexed citations
9.
Yen, Yi‐Hao, Yueh‐Wei Liu, Weifeng Li, et al.. (2023). Alpha-Fetoprotein Combined with Radiographic Tumor Burden Score to Predict Overall Survival after Liver Resection in Hepatocellular Carcinoma. Cancers. 15(4). 1203–1203. 8 indexed citations
10.
Yen, Yi‐Hao, Fang‐Ying Kuo, Hock‐Liew Eng, et al.. (2023). Tumor necrosis as a predictor of early tumor recurrence after resection in patients with hepatoma. PLoS ONE. 18(11). e0292144–e0292144. 3 indexed citations
11.
Lin, Chih‐Yun, Yi‐Hao Yen, Jing‐Houng Wang, et al.. (2022). Reappraisal of the roles of alpha-fetoprotein in hepatocellular carcinoma surveillance using large-scale nationwide database and hospital-based information. Journal of the Formosan Medical Association. 121(10). 2085–2092. 4 indexed citations
12.
Chou, Yeh‐Pin, Wei‐Chen Tai, Lung‐Sheng Lu, et al.. (2021). Endoscopic submucosal dissection and radiofrequency ablation for patients with flat‐type esophageal squamous cell neoplasia. Advances in digestive medicine. 9(3). 153–160. 1 indexed citations
13.
Chen, C.-L., et al.. (2015). Prevalence of Hypertension After Living-Donor Liver Transplantation: A Prospective Study. Transplantation Proceedings. 47(2). 445–450. 10 indexed citations
14.
Kuan, Chen‐Hsiang, et al.. (2015). Prognostic Factors of Survival From Intractable Oronasal Bleeding After Successful Transarterial Embolization. Journal of Oral and Maxillofacial Surgery. 73(9). 1790–1794. 5 indexed citations
15.
Lin, Chih‐Yun, Cho‐Kai Wu, Eng‐Kean Yeong, et al.. (2012). Prognostic Significance of Left Ventricular Diastolic Function in Burn Patients. Shock. 37(5). 457–462. 12 indexed citations
16.
Hung, Chao‐Hung, Chuan‐Mo Lee, Jing‐Houng Wang, et al.. (2010). Impact of diabetes mellitus on incidence of hepatocellular carcinoma in chronic hepatitis C patients treated with interferon‐based antiviral therapy. International Journal of Cancer. 128(10). 2344–2352. 85 indexed citations
17.
Chen, Jingyi, Jing‐Houng Wang, Chih‐Yun Lin, et al.. (2010). Lower prevalence of hypercholesterolemia and hyperglyceridemia found in subjects with seropositivity for both Hepatitis B and C strains independently. Journal of Gastroenterology and Hepatology. 25(11). 1763–1768. 44 indexed citations
18.
Changchien, Chi‐Sin, Chao‐Long Chen, Yi‐Hao Yen, et al.. (2008). Analysis of 6381 hepatocellular carcinoma patients in southern Taiwan: prognostic features, treatment outcome, and survival. Journal of Gastroenterology. 43(2). 159–170. 63 indexed citations
19.
Kee, Kwong‐Ming, Jing‐Houng Wang, Chuan‐Mo Lee, et al.. (2007). Validation of clinical AJCC/UICC TNM staging system for hepatocellular carcinoma: Analysis of 5,613 cases from a medical center in southern Taiwan. International Journal of Cancer. 120(12). 2650–2655. 82 indexed citations
20.
Lin, Chih‐Yun, Yun Chen, & Sheng‐Hong Tseng. (2006). Chronic encapsulated intracerebral haematoma. Journal of Clinical Neuroscience. 14(1). 58–61. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026